Neurolentech signs technology access partnership with Kaerus Bioscience to advance neurodevelopmental disorder research

FHS
April 22, 2024
12:54 pm

Kaerus Bioscience will access Neurolentech’s NDD Drug Discovery Platform to support development of its preclinical asset pipeline for numerous genetic syndromes.

STRIDE Regimen Shows Manageable Safety in Unresectable Liver Cancer

The use of single tremelimumab (Imjudo) and regular interval durvalumab (Imfinzi; STRIDE regimen) in patients with unresectable hepatocellular carcinoma (HCC) showed manageable and low-grade immune-mediated

July 8, 2023

Octapharma wins FDA approval for drug to urgently reverse effects of blood thinners

The FDA approved a new treatment option for adult patients who need an urgent reversal of blood thinners such as warfarin. Octapharma’s Balfaxar is now

July 27, 2023

3 Massachusetts men indicted for armed robbery of cash courier transporting $430,000 for marijuana companies – The Cannabist

Related Articles Three Bay State men have been federally indicted for the alleged armed robbery of a cash courier who was transporting more than $430,000

July 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.